These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21183765

  • 1. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.
    Niccoli G, Conte M, Cosentino N, Todaro D, Brugaletta S, Montone RA, Minelli S, Fracassi F, Galiffa V, Leone AM, Burzotta F, Porto I, Trani C, Crea F.
    J Invasive Cardiol; 2011 Jan; 23(1):16-20. PubMed ID: 21183765
    [Abstract] [Full Text] [Related]

  • 2. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
    Park DW, Lee CW, Yun SC, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.
    Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
    [Abstract] [Full Text] [Related]

  • 3. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
    Takasawa Y, Iijima R, Shiba M, Nakamura M, Sugi K.
    J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
    [Abstract] [Full Text] [Related]

  • 4. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y, Takagi K, Naganuma T, Kawamoto H, Fujino Y, Ishiguro H, Tahara S, Kurita N, Hosawa K, Nakamura S, Nakamura S.
    Int J Cardiol; 2017 Aug 01; 240():108-113. PubMed ID: 28476515
    [Abstract] [Full Text] [Related]

  • 5. Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents.
    Yin J, Shen L, Ji M, Wu Y, Cai S, Chen J, Yao Z, Ge J.
    Biomed Res Int; 2017 Aug 01; 2017():8730271. PubMed ID: 28373989
    [Abstract] [Full Text] [Related]

  • 6. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A, Ekici B, Töre HF.
    Turk Kardiyol Dern Ars; 2015 Jul 01; 43(5):457-64. PubMed ID: 26148078
    [Abstract] [Full Text] [Related]

  • 7. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C, Yang L, Mao L, Zhong L, Li X, Wei S.
    Coron Artery Dis; 2013 Aug 01; 24(5):357-60. PubMed ID: 23835667
    [Abstract] [Full Text] [Related]

  • 8. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
    Song HG, Park DW, Kim YH, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Han S, Seong IW, Lee NH, Lee BK, Lee K, Lee SW, Nah DY, Park SJ.
    J Am Coll Cardiol; 2012 Mar 20; 59(12):1093-100. PubMed ID: 22421303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of 2-year outcomes of repeated second-generation drug-eluting stent implantation for focal-type versus nonfocal-type in-stent restenosis.
    Zhu W, Li J, Luo H, Wang G, Hua Q.
    Coron Artery Dis; 2015 Nov 20; 26(7):587-91. PubMed ID: 26166020
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M, Nienaber CA, Mostafa AE, Sabin G, Tebbe U, Hochadel M, Senges J, Akin I, Kuck KH, Hamm C, Richardt G, German Drug-Eluting Stent (DES.DE) registry.
    EuroIntervention; 2011 Jun 20; 7(2):201-8. PubMed ID: 21646062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.
    Li JJ, Xu B, Yang YJ, Ma WH, Chen JL, Qiao SB, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.
    Chin Med J (Engl); 2006 Jul 05; 119(13):1059-64. PubMed ID: 16834923
    [Abstract] [Full Text] [Related]

  • 20. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
    Katsaros KM, Kastl SP, Zorn G, Maurer G, Wojta J, Huber K, Christ G, Speidl WS.
    JACC Cardiovasc Interv; 2010 Jan 05; 3(1):90-7. PubMed ID: 20129576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.